Eledon Pharmaceuticals
0 followers
Eledon Pharmaceuticals, Inc. is a clinical stage biotechnology company using its expertise in targeting the CD40L pathway to develop potential treatments for people undergoing organ or cellular transplantation, and for people with autoimmune and neurodegenerative disease.
Org chart
David-Alexandre C. Gros
Chief Executive Officer
David-Alexandre C. Gros
Collapse
Steven Perrin
President & Chief Scientific Officer
Paul Little
Chief Financial Officer
David Hovland
Chief Regulatory Officer
Bryan Smith
General Counsel
John Herberger
VP, Technical Operations
Carmen Mak
VP, Biometrics
Eliezer Katz
Chief Medical Officer
